Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness of NeoMayor in Improving Cardiovascular Health in Chilean Older Adults

NCT: NCT07633392 · NOT_YET_RECRUITING

NCT IDNCT07633392
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2027-05
SponsorUniversity of Chile (OTHER)
First posted
Last updated

Brief Summary

This study aims to evaluate the effectiveness of NeoMayor, a mobile health (mHealth) intervention designed to improve cardiovascular health among older adults at elevated cardiovascular risk in Chile. NeoMayor is a smartphone-based application that provides personalized guidance on physical activity, diet, sleep, and mental well-being through a multidomain lifestyle approach. This multicenter randomized controlled trial will enroll community-dwelling older adults aged 55 to 75 years recruited from primary healthcare centers in urban and rural settings. Participants will be randomized in a 2:1 ratio to either the NeoMayor intervention or a control group receiving standard health information and usual care. The intervention duration will be four months. The primary objective is to determine whether the NeoMayor intervention improves cardiovascular health as measured by the Life's Essential 8 Cardiovascular Health Index. Secondary objectives include evaluating changes in cognitive performance, depressive symptoms, anxiety symptoms, quality of life and physical performance outcomes. The study will also assess feasibility and adherence to digital intervention.

Frequently Asked Questions

What is Effectiveness of NeoMayor in Improving Cardiovascular Health in Chilean Older Adults?

Effectiveness of NeoMayor in Improving Cardiovascular Health in Chilean Older Adults is a clinical trial registered under NCT07633392. Current status: NOT_YET_RECRUITING.

What is the status of NCT07633392?

The current status of NCT07633392 (Effectiveness of NeoMayor in Improving Cardiovascular Health in Chilean Older Adults) is: NOT_YET_RECRUITING.

When did Effectiveness of NeoMayor in Improving Cardiovascular Health in Chilean Older Adults start?

Effectiveness of NeoMayor in Improving Cardiovascular Health in Chilean Older Adults started on 2026-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.